## Abstract In the current study, we evaluated the efficiency of folate‐polyamidoamine dendrimers conjugates (FA‐PAMAM) for the __in situ__ delivery of therapeutic antisense oligonucleotides (ASODN) that could inhibit the growth of C6 glioma cells. Folic acid was coupled to the surface amino groups
The in vitro and in vivo pharmacology of antisense oligonucleotides targeted to murine Stat6
✍ Scribed by H. Danahay; S. Hill; F. Natt; C.E. Owen
- Publisher
- SP Birkhäuser Verlag Basel
- Year
- 2000
- Tongue
- English
- Weight
- 209 KB
- Volume
- 49
- Category
- Article
- ISSN
- 1420-908X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The expression of MRP1 (multidrug resistance protein‐1) is associated with chemoresistance and poor prognosis in neuroblastoma. MRP1 antisense oligonucleotides were used in an __in vivo__ mouse‐human xenograft model of neuroblastoma to downregulate MRP1. The MRP1 ASO reduced protein lev
## Abstract ## Background Targeted splice modulation of pre‐mRNA transcripts by antisense oligonucleotides (AOs) can correct the function of aberrant disease‐related genes. Duchenne muscular dystrophy (DMD) arises as a result of mutations that interrupt the open‐reading frame in the DMD gene encod